Seeking Alpha

Introgen Therapeutics, Inc. (INGN) ()

Authors on INGN

Newest on INGN
  1. The Biotech Onion (1)
  2. EP Vantage (1)
  3. ChinaBio Today (1)
  4. Mike Havrilla (1)
  5. Charles Atan (2)
Most frequent on INGN
  1. Alan Brochstein (5)
  2. Centient Biotech Investor (2)
  3. Charles Atan (2)
  4. EP Vantage (1)
  5. ChinaBio Today (1)
Most followed on INGN
Most commented on INGN
  1. Alan Brochstein (8)
  2. The Biotech Onion (6)
  3. Mike Havrilla (2)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:

Articles on Introgen Therapeutics, Inc. (INGN) by latest  |  most commented